| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.49e-04 | 18 | 35 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.10e-03 | 28 | 35 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.91e-03 | 37 | 35 | 2 | GO:0045505 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.15e-04 | 10 | 34 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | axoneme | 3.43e-04 | 207 | 34 | 4 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 3.50e-04 | 208 | 34 | 4 | GO:0097014 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 7.52e-04 | 25 | 34 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.68e-03 | 317 | 34 | 4 | GO:0032838 | |
| GeneOntologyCellularComponent | motile cilium | 2.54e-03 | 355 | 34 | 4 | GO:0031514 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.67e-03 | 360 | 34 | 4 | GO:0099568 | |
| GeneOntologyCellularComponent | dynein complex | 3.48e-03 | 54 | 34 | 2 | GO:0030286 | |
| Domain | ATPase_dyneun-rel_AAA | 3.06e-04 | 14 | 35 | 2 | IPR011704 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.06e-04 | 14 | 35 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.06e-04 | 14 | 35 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.06e-04 | 14 | 35 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.06e-04 | 14 | 35 | 2 | PF08393 | |
| Domain | MT | 3.06e-04 | 14 | 35 | 2 | PF12777 | |
| Domain | AAA_8 | 3.06e-04 | 14 | 35 | 2 | PF12780 | |
| Domain | AAA_5 | 3.06e-04 | 14 | 35 | 2 | PF07728 | |
| Domain | DHC_fam | 3.53e-04 | 15 | 35 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.53e-04 | 15 | 35 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 3.53e-04 | 15 | 35 | 2 | PF03028 | |
| Domain | - | 1.41e-03 | 449 | 35 | 5 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.55e-03 | 459 | 35 | 5 | IPR013083 | |
| Domain | RING | 2.45e-03 | 305 | 35 | 4 | SM00184 | |
| Domain | Znf_RING | 3.11e-03 | 326 | 35 | 4 | IPR001841 | |
| Domain | Zinc_finger_PHD-type_CS | 6.59e-03 | 65 | 35 | 2 | IPR019786 | |
| Domain | PHD | 8.69e-03 | 75 | 35 | 2 | PF00628 | |
| Domain | Ank | 8.81e-03 | 228 | 35 | 3 | PF00023 | |
| Domain | Znf_PHD-finger | 9.60e-03 | 79 | 35 | 2 | IPR019787 | |
| Domain | - | 1.11e-02 | 248 | 35 | 3 | 1.25.40.20 | |
| Domain | ANK | 1.14e-02 | 251 | 35 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 1.17e-02 | 253 | 35 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.18e-02 | 254 | 35 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.18e-02 | 254 | 35 | 3 | PS50297 | |
| Domain | PHD | 1.21e-02 | 89 | 35 | 2 | SM00249 | |
| Domain | Znf_PHD | 1.26e-02 | 91 | 35 | 2 | IPR001965 | |
| Domain | Ankyrin_rpt | 1.28e-02 | 262 | 35 | 3 | IPR002110 | |
| Domain | ZF_PHD_2 | 1.37e-02 | 95 | 35 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 1.39e-02 | 96 | 35 | 2 | PS01359 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 39056782 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 20138174 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 20732415 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 32591397 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.39e-05 | 361 | 36 | 5 | 26167880 | |
| Pubmed | 9.41e-05 | 14 | 36 | 2 | 9373155 | ||
| Pubmed | 1.47e-04 | 493 | 36 | 5 | 15368895 | ||
| Pubmed | 1.58e-04 | 101 | 36 | 3 | 10997877 | ||
| Pubmed | 1.96e-04 | 20 | 36 | 2 | 21689717 | ||
| Pubmed | 3.60e-04 | 27 | 36 | 2 | 18685082 | ||
| Pubmed | 6.33e-04 | 162 | 36 | 3 | 15174051 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 7.28e-04 | 1489 | 36 | 7 | 28611215 | |
| Pubmed | 9.20e-04 | 1116 | 36 | 6 | 31753913 | ||
| Interaction | KYAT1 interactions | 5.36e-06 | 20 | 35 | 3 | int:KYAT1 | |
| GeneFamily | Dyneins, axonemal | 1.90e-04 | 17 | 22 | 2 | 536 | |
| GeneFamily | Ankyrin repeat domain containing | 3.02e-03 | 242 | 22 | 3 | 403 | |
| GeneFamily | PHD finger proteins | 5.31e-03 | 90 | 22 | 2 | 88 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.57e-05 | 188 | 36 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.88e-05 | 197 | 36 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.96e-05 | 199 | 36 | 4 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 120 | 36 | 3 | eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 142 | 36 | 3 | 01c39bb90807fa3031ba4511712440380b6069af | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.08e-04 | 143 | 36 | 3 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-04 | 154 | 36 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-04 | 154 | 36 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-04 | 154 | 36 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-04 | 154 | 36 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.63e-04 | 155 | 36 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.63e-04 | 155 | 36 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 2.68e-04 | 156 | 36 | 3 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, Lineage and Cell Type | 2.84e-04 | 159 | 36 | 3 | f6ad73b6a3681471efbd4fafd9eb631764c53500 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-04 | 161 | 36 | 3 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.34e-04 | 168 | 36 | 3 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-04 | 169 | 36 | 3 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.51e-04 | 171 | 36 | 3 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.51e-04 | 171 | 36 | 3 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | Healthy/Control-Plasmablast|World / Disease group and Cell class | 3.57e-04 | 172 | 36 | 3 | d3bfcf5d936152b71cd90f955f9331709edd979e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Ddit4l_(Neurofilament,_Layer4?)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.64e-04 | 35 | 36 | 2 | afb8cd52dffd630ffe8e7812874d5fd52e0b6752 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.70e-04 | 174 | 36 | 3 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | Healthy/Control-Plasmablast|Healthy/Control / Disease group and Cell class | 3.70e-04 | 174 | 36 | 3 | 97d19ef3240a1f648c6befaabb9ce45ad469cbce | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.76e-04 | 175 | 36 | 3 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | Healthy_donor-Plasmablast|World / disease group, cell group and cell class (v2) | 3.76e-04 | 175 | 36 | 3 | 5293e00fda63a291aa393bdf82ebd4b80265049f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-04 | 177 | 36 | 3 | 164ffbbf798defa3728197deb1a14b661490e525 | |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | 3.88e-04 | 177 | 36 | 3 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 | |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | 3.88e-04 | 177 | 36 | 3 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 178 | 36 | 3 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Healthy_donor-Plasmablast|Healthy_donor / disease group, cell group and cell class (v2) | 3.95e-04 | 178 | 36 | 3 | 388b8b4fa20dcc6e9ae4b06118e20b2c20c52bde | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.95e-04 | 178 | 36 | 3 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-04 | 179 | 36 | 3 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-04 | 179 | 36 | 3 | 065a50952e8703fa07767beb6b73a090bf378ca6 | |
| ToppCell | BLOOD--(5)_Plasma| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.08e-04 | 180 | 36 | 3 | 1ac0a0a715f4a36df0762bb0de44802d6ffa284c | |
| ToppCell | BLOOD--(5)_Plasmablasts| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.08e-04 | 180 | 36 | 3 | 4b9be1b19d4ecd0a3b924e4557a1ecfbcff2d705 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.08e-04 | 180 | 36 | 3 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-04 | 183 | 36 | 3 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-04 | 183 | 36 | 3 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-04 | 183 | 36 | 3 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 184 | 36 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 184 | 36 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 184 | 36 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.35e-04 | 184 | 36 | 3 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 4.42e-04 | 185 | 36 | 3 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.42e-04 | 185 | 36 | 3 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 186 | 36 | 3 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 186 | 36 | 3 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.49e-04 | 186 | 36 | 3 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 187 | 36 | 3 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 187 | 36 | 3 | 0334fb1247a5800bf1438a48da8fd905df000d89 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 187 | 36 | 3 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 187 | 36 | 3 | cf8e3448402e1d05b8321a5f124bd29e30e18841 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 187 | 36 | 3 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | severe_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2) | 4.63e-04 | 188 | 36 | 3 | 25ca19af4ac419a0f5026a6ccbd8b554b268a6f3 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 188 | 36 | 3 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 188 | 36 | 3 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-04 | 189 | 36 | 3 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.78e-04 | 190 | 36 | 3 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.78e-04 | 190 | 36 | 3 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 190 | 36 | 3 | e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 190 | 36 | 3 | fe844559b95832845d2e8d3ab4b57e3d558bc372 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.78e-04 | 190 | 36 | 3 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.85e-04 | 191 | 36 | 3 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.85e-04 | 191 | 36 | 3 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-04 | 191 | 36 | 3 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-04 | 191 | 36 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.85e-04 | 191 | 36 | 3 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-04 | 191 | 36 | 3 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 4.92e-04 | 192 | 36 | 3 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.92e-04 | 192 | 36 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.00e-04 | 193 | 36 | 3 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.08e-04 | 194 | 36 | 3 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-04 | 194 | 36 | 3 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.08e-04 | 194 | 36 | 3 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.08e-04 | 194 | 36 | 3 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 5.23e-04 | 196 | 36 | 3 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-04 | 196 | 36 | 3 | f37ffb916480281e5905733ac304102dd2e0c05f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.23e-04 | 196 | 36 | 3 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.23e-04 | 196 | 36 | 3 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_mature|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-04 | 196 | 36 | 3 | 4b9eb163b9dbbf5eebb160f6554f6f28cb234d31 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 5.23e-04 | 196 | 36 | 3 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.31e-04 | 197 | 36 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-04 | 197 | 36 | 3 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 5.39e-04 | 198 | 36 | 3 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.39e-04 | 198 | 36 | 3 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.39e-04 | 198 | 36 | 3 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.39e-04 | 198 | 36 | 3 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.39e-04 | 198 | 36 | 3 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-04 | 198 | 36 | 3 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.46e-04 | 199 | 36 | 3 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.46e-04 | 199 | 36 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.46e-04 | 199 | 36 | 3 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.46e-04 | 199 | 36 | 3 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 5.46e-04 | 199 | 36 | 3 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | distal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.46e-04 | 199 | 36 | 3 | 7e5f29f4ec1fea92f2c0064eea151d2d474ef904 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.46e-04 | 199 | 36 | 3 | 58242d78517c05fa367a7c6edac57ef79107453c | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.46e-04 | 199 | 36 | 3 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.46e-04 | 199 | 36 | 3 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.46e-04 | 199 | 36 | 3 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.46e-04 | 199 | 36 | 3 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.36e-05 | 50 | 18 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | disease recurrence, colon carcinoma | 2.80e-05 | 51 | 34 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | immunoglobulin isotype switching measurement | 1.18e-03 | 44 | 34 | 2 | EFO_0010128 | |
| Disease | forced expiratory volume, response to bronchodilator | 1.65e-03 | 445 | 34 | 4 | EFO_0004314, GO_0097366 | |
| Disease | psychotic symptoms | 3.30e-03 | 74 | 34 | 2 | EFO_0005940 | |
| Disease | serum albumin measurement | 4.62e-03 | 592 | 34 | 4 | EFO_0004535 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVVNKQCKECENVKE | 411 | Q4LE39 | |
| QCKECENVKEIKVKE | 416 | Q4LE39 | |
| VKELVVNVCDKCKIS | 311 | P30939 | |
| CEDTVEKLQAECRKL | 811 | A6NC57 | |
| CKENCVDVKLERAKI | 1776 | Q8IYW2 | |
| EKCIEKQERFCQLKK | 1711 | A6QL64 | |
| IQDEELKKFCSRICK | 16 | O43299 | |
| EIICDKVQVKLSKEC | 46 | Q8TBE9 | |
| QCREEVEKVKCFLEK | 26 | Q86YV6 | |
| KIEDEVTRQVAQCKC | 7121 | Q9UPN3 | |
| LQEFCEKDFIKKVCQ | 116 | Q3MIT2 | |
| RECITKKEELELKCE | 3096 | Q9P2D7 | |
| KKEELELKCEQCEQR | 3101 | Q9P2D7 | |
| LIKCCKEEKVVFALT | 3496 | Q9C0G6 | |
| NTKVDKTVERKCCVE | 91 | P01859 | |
| CDCKIFKICLVVTKE | 41 | Q8NEC7 | |
| DRKIACAAVDCVKDK | 446 | Q14554 | |
| VKCIEELCQKREELC | 16 | O43805 | |
| CVRKLLCQEKDKDVL | 651 | Q6NUP7 | |
| CEVKKEVELLTDFLC | 206 | Q17RQ9 | |
| LKEQEERKKCVICQD | 371 | Q9BY78 | |
| KDICKIRCLCEEKEN | 26 | Q9H156 | |
| FAEKLLKQLECCKER | 296 | Q9NVU7 | |
| KCCEDIKENKVTICR | 36 | Q8N1H7 | |
| IVEDIKKKCCFVALD | 271 | Q9Y615 | |
| KVDEDCEECQKAKDR | 461 | Q8TCY9 | |
| IKVECEVEEIDQCTK | 36 | Q9BQY6 | |
| VKDKVFKDNCCKREI | 96 | Q13114 | |
| TCKTIEECCRKQKQE | 196 | Q9BYV6 | |
| EECCRKQKQELCEKF | 201 | Q9BYV6 | |
| ENLQLKKCCKRVDEC | 121 | P0CB33 | |
| IAKVDCKEVLDIICN | 271 | Q13129 | |
| QIDICEDVKIKCSKQ | 31 | Q9BX26 | |
| CVKCCAEEDKKTEIL | 766 | Q92576 | |
| KAKCCEEELDFRAVV | 31 | Q9ULI2 | |
| VAECKALALECERVK | 471 | Q9BZF9 | |
| RKCKQVKEKCKEEFV | 526 | Q15326 | |
| EKDLQDVLKCCLKRD | 761 | P33981 | |
| IKEIIGECICKNKEE | 426 | Q9Y3S1 | |
| GECICKNKEERYEIK | 431 | Q9Y3S1 | |
| CLILDDCEKREIKKV | 166 | Q8IYH5 |